{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:50:42Z","timestamp":1773859842730,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1124\/mol.63.3.659","type":"journal-article","created":{"date-parts":[[2003,2,27]],"date-time":"2003-02-27T18:30:53Z","timestamp":1046370653000},"page":"659-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders"],"prefix":"10.1016","volume":"63","author":[{"given":"Jean-Fran\u00e7ois","family":"Desaphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabata","family":"Pierno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Didonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Conte","family":"Camerino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.63.3.659_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00695196","article-title":"Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea pig papillary muscles","volume":"329","author":"Ban","year":"1985","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1124\/mol.63.3.659_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1085\/jgp.81.5.613","article-title":"Lidocaine block of cardiac sodium channels","volume":"81","author":"Bean","year":"1983","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.63.3.659_bib3","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1073\/pnas.92.26.12003","article-title":"Serine-1321-independent regulation of the \u03bc1 adult skeletal muscle Na+ channel by protein kinase C","volume":"92","author":"Bendahhou","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.63.3.659_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0031-6997(25)06871-1","article-title":"Actions of sympathomimetic amines and their antagonists on skeletal muscle","volume":"21","author":"Bowman","year":"1969","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.63.3.659_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1566-2772(00)00011-6","article-title":"Voltage-gated ion channelopathies of the nervous system","volume":"1","author":"Cannon","year":"2001","journal-title":"Clin Neurosci Res"},{"key":"10.1124\/mol.63.3.659_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bjp.0703369","article-title":"Betaxolol, a \u03b21-adrenoceptor antagonist reduces Na+ influx into cortical synaptosomes by direct interaction with Na+ channels: comparison with other \u03b2-adrenoceptor antagonists","volume":"130","author":"Chidlow","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.63.3.659_bib7","first-page":"E50","article-title":"Anabolic effects of clenbuterol on skeletal muscle are mediated by \u03b22-adrenoceptor activation","volume":"263","author":"Choo","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.63.3.659_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1113\/jphysiol.1993.sp019960","article-title":"Na+-K+ pump stimulation elicits recovery of contractility in K+-paralysed rat muscle","volume":"472","author":"Clausen","year":"1993","journal-title":"J Physiol"},{"key":"10.1124\/mol.63.3.659_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0026-895X(25)11029-8","article-title":"Sodium channel blockers: the size\/solubility hypothesis revisited","volume":"37","author":"Courtney","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.63.3.659_bib10","doi-asserted-by":"crossref","first-page":"C1465","DOI":"10.1152\/ajpcell.1998.275.6.C1465","article-title":"Blockade by cAMP of native sodium channels of rat skeletal muscle fibers","volume":"275","author":"Desaphy","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.63.3.659_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-3565(24)37668-2","article-title":"Partial recovery of skeletal muscle sodium channel properties in aged rats chronically treated with growth hormone or the GH-secretagogue hexarelin","volume":"286","author":"Desaphy","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.63.3.659_bib12","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1212\/WNL.57.10.1849","article-title":"Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative","volume":"57","author":"Desaphy","year":"2001","journal-title":"Neurology"},{"key":"10.1124\/mol.63.3.659_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s002100000341","article-title":"Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol","volume":"363","author":"Fischer","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1124\/mol.63.3.659_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-3565(25)28443-9","article-title":"The site of action and active form of local anesthetics. Experiments with quaternary compounds","volume":"171","author":"Frazier","year":"1970","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.63.3.659_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.65.2.248","article-title":"Salbutamol treatment in a patient with hyperkalemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A)","volume":"65","author":"Hanna","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1124\/mol.63.3.659_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-510X(98)00084-7","article-title":"Examining potential drug therapies for muscular dystrophy utilizing the dy\/dy mouse: I. Clenbuterol","volume":"157","author":"Hayes","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1124\/mol.63.3.659_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/apmr.2001.23756","article-title":"Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats","volume":"82","author":"Herrera","year":"2001","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1124\/mol.63.3.659_bib18","series-title":"Ion Channels of Excitable Membranes.","author":"Hille","year":"2001"},{"key":"10.1124\/mol.63.3.659_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mus.10092","article-title":"Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the \u03b22-adrenergic receptor","volume":"25","author":"Hinkle","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1124\/mol.63.3.659_bib20","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.57.8.1434","article-title":"Randomized, double-blind, placebo-controlled trial of albuterol in fascioscapulohumeral dystrophy","volume":"57","author":"Kissel","year":"2001","journal-title":"Neurology"},{"key":"10.1124\/mol.63.3.659_bib21","first-page":"E795","article-title":"Characterization of \u03b2-adrenergic receptors of human skeletal muscle obtained by needle biopsy","volume":"254","author":"Liggett","year":"1988","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1124\/mol.63.3.659_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1469-7793.1999.0371p.x","article-title":"Modulation of rat cardiac sodium channel by the stimulatory G protein \u03b1 subunit","volume":"518","author":"Lu","year":"1999","journal-title":"J Physiol"},{"key":"10.1124\/mol.63.3.659_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/cs0840651","article-title":"Clenbuterol, a \u03b2-adrenoreceptor agonist, increases relative muscle strength in orthopedic patients","volume":"84","author":"Maltin","year":"1993","journal-title":"Clin Sci"},{"key":"10.1124\/mol.63.3.659_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/01.RES.70.1.199","article-title":"Enhancement of rabbit cardiac sodium channel by \u03b2-adrenergic stimulation","volume":"70","author":"Matsuda","year":"1992","journal-title":"Circ Res"},{"key":"10.1124\/mol.63.3.659_bib25","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/0006-2952(82)90668-2","article-title":"Effect of propranolol and a number of its analogues on sodium channels","volume":"31","author":"Matthews","year":"1982","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.63.3.659_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00019052-200010000-00003","article-title":"Myotonic dystrophies","volume":"13","author":"Meola","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1124\/mol.63.3.659_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11940-000-0022-1","article-title":"Channelopathies","volume":"2","author":"Moxley","year":"2000","journal-title":"Curr Treatment Opt Neurol"},{"key":"10.1124\/mol.63.3.659_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0026-895X(24)12652-1","article-title":"Point mutations at N434 in D1\u2013S6 of \u03bc1 Na+ channels modulate binding affinity and stereoselectivity of local anesthetic enantiomers","volume":"56","author":"Nau","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.63.3.659_bib29","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1126\/science.8085162","article-title":"Molecular determinants of state-dependent block of Na+ channels by local anesthetics","volume":"265","author":"Ragsdale","year":"1994","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.63.3.659_bib30","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1073\/pnas.93.17.9270","article-title":"Common molecular determinants of local anesthetic, antiarrhythmic and anticonvulsant block of voltage-gated Na+ channels","volume":"93","author":"Ragsdale","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.63.3.659_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1113\/jphysiol.2001.012541","article-title":"Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na+ channel","volume":"537","author":"Takahashi","year":"2001","journal-title":"J Physiol"},{"key":"10.1124\/mol.63.3.659_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000056184","article-title":"Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats","volume":"65","author":"Von Deutsch","year":"2002","journal-title":"Pharmacology"},{"key":"10.1124\/mol.63.3.659_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(76)91340-4","article-title":"Treatment of hyperkalemic periodic paralysis by inhalation of salbutamol","volume":"1","author":"Wang","year":"1976","journal-title":"Lancet"},{"key":"10.1124\/mol.63.3.659_bib34","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0006-3495(00)76390-9","article-title":"Residues in Na+ channel D3\u2013S6 segment modulate both batrachotoxin and local anesthetic affinities","volume":"79","author":"Wang","year":"2000","journal-title":"Biophys J"},{"key":"10.1124\/mol.63.3.659_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2610001","article-title":"Multiple actions of \u03b2-adrenergic agonists on skeletal muscle and adipose tissue","volume":"261","author":"Yang","year":"1989","journal-title":"Biochem J"},{"key":"10.1124\/mol.63.3.659_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1074\/jbc.M006992200","article-title":"Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na+ channel \u03b1-subunit","volume":"276","author":"Yarov-Yarovoy","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.63.3.659_bib37","doi-asserted-by":"crossref","unstructured":"Yarov-Yarovoy V McPhee JC Idsvoog D Pate C, Scheuer T Catterall WA 2002 Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel \u03b1 subunit in voltage-dependent gating and drug block July 18 2002 J Biol Chem 10.1074\/jbc.M206126200","DOI":"10.1074\/jbc.M206126200"},{"key":"10.1124\/mol.63.3.659_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<521::AID-MUS10>3.0.CO;2-8","article-title":"Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle","volume":"23","author":"Zeman","year":"2000","journal-title":"Muscle Nerve"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24057663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24057663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.63.3.659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:51:51Z","timestamp":1740041511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24057663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0026895X24057663"],"URL":"https:\/\/doi.org\/10.1124\/mol.63.3.659","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different Ability of Clenbuterol and Salbutamol to Block Sodium Channels Predicts Their Therapeutic Use in Muscle Excitability Disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.63.3.659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}